US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.940
  • +0.090+3.16%
Close Apr 26 16:00 ET
  • 2.970
  • +0.030+1.01%
Post 19:31 ET
356.63MMarket Cap-1986P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
50,563.64%5.57M
38,845.45%4.28M
18,409.09%2.04M
Operating revenue
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
50,563.64%5.57M
38,845.45%4.28M
18,409.09%2.04M
Cost of revenue
Gross profit
Operating expense
-9.78%207.81M
-47.73%31.63M
-33.41%43.43M
19.85%67.16M
35.02%65.6M
36.38%230.35M
25.96%60.51M
43.64%65.21M
37.21%56.03M
40.33%48.59M
Selling and administrative expenses
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
43.95%14.57M
66.64%14.8M
77.33%12.78M
-General and administrative expense
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
43.95%14.57M
66.64%14.8M
77.33%12.78M
Research and development costs
-14.49%148.27M
-52.97%21.5M
-39.71%30.53M
18.77%48.97M
32.03%47.28M
31.34%173.39M
22.32%45.71M
43.55%50.64M
29.03%41.23M
30.61%35.81M
Operating profit
16.10%-170.96M
54.33%-20.93M
40.09%-35.73M
-9.18%-56.5M
-24.16%-57.8M
-20.67%-203.77M
4.59%-45.83M
-31.40%-59.64M
-26.75%-51.75M
-34.50%-46.55M
Net non-operating interest income expense
1,897.75%8M
108.76%1.88M
1,428.49%2.29M
567.80%2.19M
332.01%1.64M
62.98%-445K
194.75%902K
-107.23%-172K
-445.35%-469K
-771.60%-706K
Non-operating interest income
318.77%12.07M
57.07%2.93M
366.38%3.3M
1,006.19%3.22M
14,461.11%2.62M
4,335.38%2.88M
6,334.48%1.87M
4,620.00%708K
3,133.33%291K
50.00%18K
Non-operating interest expense
22.39%4.07M
8.71%1.05M
15.57%1.02M
34.87%1.03M
35.77%983K
162.67%3.33M
-1.73%964K
797.96%880K
700.00%760K
678.49%724K
Other net income (expense)
-8.71M
-499K
-8.21M
Special income (charges)
---8.71M
---499K
---8.21M
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
--8.71M
--499K
--8.21M
----
----
--0
--0
--0
----
----
Income before tax
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
-27.63%-52.22M
-36.22%-47.26M
Income tax
Net income
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
-27.63%-52.22M
-36.22%-47.26M
Net income continuous Operations
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
-27.63%-52.22M
-36.22%-47.26M
Minority interest income
Net income attributable to the parent company
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
-27.63%-52.22M
-36.22%-47.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
-27.63%-52.22M
-36.22%-47.26M
Basic earnings per share
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
3.17%-0.61
6.78%-0.55
-18.00%-0.59
Diluted earnings per share
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
3.17%-0.61
6.78%-0.55
-18.00%-0.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M61,716.28%26.58M133,427.27%14.69M50,563.64%5.57M38,845.45%4.28M18,409.09%2.04M
Operating revenue 38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M61,716.28%26.58M133,427.27%14.69M50,563.64%5.57M38,845.45%4.28M18,409.09%2.04M
Cost of revenue
Gross profit
Operating expense -9.78%207.81M-47.73%31.63M-33.41%43.43M19.85%67.16M35.02%65.6M36.38%230.35M25.96%60.51M43.64%65.21M37.21%56.03M40.33%48.59M
Selling and administrative expenses 4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M54.42%56.96M38.70%14.81M43.95%14.57M66.64%14.8M77.33%12.78M
-General and administrative expense 4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M54.42%56.96M38.70%14.81M43.95%14.57M66.64%14.8M77.33%12.78M
Research and development costs -14.49%148.27M-52.97%21.5M-39.71%30.53M18.77%48.97M32.03%47.28M31.34%173.39M22.32%45.71M43.55%50.64M29.03%41.23M30.61%35.81M
Operating profit 16.10%-170.96M54.33%-20.93M40.09%-35.73M-9.18%-56.5M-24.16%-57.8M-20.67%-203.77M4.59%-45.83M-31.40%-59.64M-26.75%-51.75M-34.50%-46.55M
Net non-operating interest income expense 1,897.75%8M108.76%1.88M1,428.49%2.29M567.80%2.19M332.01%1.64M62.98%-445K194.75%902K-107.23%-172K-445.35%-469K-771.60%-706K
Non-operating interest income 318.77%12.07M57.07%2.93M366.38%3.3M1,006.19%3.22M14,461.11%2.62M4,335.38%2.88M6,334.48%1.87M4,620.00%708K3,133.33%291K50.00%18K
Non-operating interest expense 22.39%4.07M8.71%1.05M15.57%1.02M34.87%1.03M35.77%983K162.67%3.33M-1.73%964K797.96%880K700.00%760K678.49%724K
Other net income (expense) -8.71M-499K-8.21M
Special income (charges) ---8.71M---499K---8.21M----------0--0--0--------
-Less：Restructuring and merger&acquisition --8.71M--499K--8.21M----------0--0--0--------
Income before tax 15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M-27.63%-52.22M-36.22%-47.26M
Income tax
Net income 15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M-27.63%-52.22M-36.22%-47.26M
Net income continuous Operations 15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M-27.63%-52.22M-36.22%-47.26M
Minority interest income
Net income attributable to the parent company 15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M-27.63%-52.22M-36.22%-47.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M-27.63%-52.22M-36.22%-47.26M
Basic earnings per share 32.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.529.54%-2.1835.29%-0.443.17%-0.616.78%-0.55-18.00%-0.59
Diluted earnings per share 32.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.529.54%-2.1835.29%-0.443.17%-0.616.78%-0.55-18.00%-0.59
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg